This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Innocoll Pharmaceuticals Ltd.
Innocoll Pharmaceuticals Ltd., headquartered in Ireland (IE), is a prominent player in the biopharmaceutical industry, specialising in innovative drug delivery systems and advanced wound care solutions. Founded in 2003, the company has made significant strides in developing unique products that address unmet medical needs, particularly in the fields of orthopaedics and surgical care. Innocoll's core offerings include its proprietary collagen-based products, which stand out for their biocompatibility and effectiveness in promoting healing. With a strong focus on research and development, Innocoll has achieved notable milestones, including successful clinical trials and strategic partnerships that enhance its market position. As a leader in its sector, Innocoll Pharmaceuticals continues to drive advancements in patient care, solidifying its reputation as a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Innocoll Pharmaceuticals Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Innocoll Pharmaceuticals Ltd.'s score of 13 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Innocoll Pharmaceuticals Ltd.'s reported carbon emissions
Innocoll Pharmaceuticals Ltd., headquartered in Ireland (IE), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established any documented reduction targets or commitments to climate initiatives, which suggests a lack of formalised climate strategy at this time. It is important to note that Innocoll Pharmaceuticals Ltd. is a current subsidiary and may inherit climate-related data and commitments from its parent organisation. However, no specific details regarding such cascaded data or initiatives have been provided. As the pharmaceutical industry increasingly focuses on sustainability and carbon reduction, Innocoll Pharmaceuticals Ltd. may need to consider developing its own climate commitments to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Innocoll Pharmaceuticals Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
